1. Home
  2. ACET vs NTIC Comparison

ACET vs NTIC Comparison

Compare ACET & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.58

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Logo Northern Technologies International Corporation

NTIC

Northern Technologies International Corporation

HOLD

Current Price

$9.14

Market Cap

82.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACET
NTIC
Founded
1947
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
71.3M
82.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACET
NTIC
Price
$8.58
$9.14
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$65.33
N/A
AVG Volume (30 Days)
208.6K
24.4K
Earning Date
03-05-2026
01-08-2026
Dividend Yield
N/A
0.44%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$86,204,962.00
Revenue This Year
N/A
$11.40
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.15
$6.75
52 Week High
$17.44
$12.53

Technical Indicators

Market Signals
Indicator
ACET
NTIC
Relative Strength Index (RSI) 78.42 56.77
Support Level $7.76 $8.96
Resistance Level $8.55 $9.97
Average True Range (ATR) 0.45 0.54
MACD -0.14 0.02
Stochastic Oscillator 73.85 57.21

Price Performance

Historical Comparison
ACET
NTIC

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.

Share on Social Networks: